HEADER TRANSFERASE/TRANSFERASE INHIBITOR 09-JUN-16 5B7V TITLE HUMAN FGFR1 KINASE IN COMPLEX WITH CH5183284 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TYROSINE KINASE DOMAIN, UNP RESIDUES 456-765; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS PROTEIN KINASE, ATP-BINDING, INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.A.FUKAMI,C.M.LUKACS,C.JANSON REVDAT 2 08-NOV-23 5B7V 1 REMARK REVDAT 1 22-JUN-16 5B7V 0 SPRSDE 22-JUN-16 5B7V 3WJ6 JRNL AUTH Y.NAKANISHI,N.AKIYAMA,T.TSUKAGUCHI,T.FUJII,K.SAKATA,H.SASE, JRNL AUTH 2 T.ISOBE,K.MORIKAMI,H.SHINDOH,T.MIO,H.EBIIKE,N.TAKA,Y.AOKI, JRNL AUTH 3 N.ISHII JRNL TITL THE FIBROBLAST GROWTH FACTOR RECEPTOR GENETIC STATUS AS A JRNL TITL 2 POTENTIAL PREDICTOR OF THE SENSITIVITY TO CH5183284/DEBIO JRNL TITL 3 1347, A NOVEL SELECTIVE FGFR INHIBITOR JRNL REF MOL.CANCER THER. V. 13 2547 2014 JRNL REFN ESSN 1538-8514 JRNL PMID 25169980 JRNL DOI 10.1158/1535-7163.MCT-14-0248 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 39308 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1983 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.67 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2867 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2729 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE : 0.2650 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.81 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 138 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4446 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 75 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.22890 REMARK 3 B22 (A**2) : -25.04300 REMARK 3 B33 (A**2) : 10.81410 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.37160 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.360 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.917 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.893 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4598 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6217 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1619 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 111 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 643 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4598 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 572 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5042 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.82 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.87 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5B7V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1300000606. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-AUG-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48444 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 43.351 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03300 REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.69600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1GAG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 10000, (NH4)2SO4, BIS-TRIS, PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 105.60500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.37500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 105.60500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.37500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 456 REMARK 465 VAL A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 GLY A 490 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 ASP A 647 REMARK 465 ILE A 648 REMARK 465 HIS A 649 REMARK 465 GLN A 764 REMARK 465 GLU A 765 REMARK 465 MET B 456 REMARK 465 VAL B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 SER B 461 REMARK 465 GLY B 487 REMARK 465 ALA B 488 REMARK 465 PHE B 489 REMARK 465 LYS B 502 REMARK 465 ASP B 503 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 ASN B 659 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 ASP A 503 CG OD1 OD2 REMARK 470 GLU A 592 CG CD OE1 OE2 REMARK 470 LYS B 482 CE NZ REMARK 470 ASP B 501 CG OD1 OD2 REMARK 470 LYS B 504 CG CD CE NZ REMARK 470 LYS B 655 CG CD CE NZ REMARK 470 LYS B 656 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 484 -65.69 -120.16 REMARK 500 ASP A 519 35.85 -92.18 REMARK 500 ARG A 622 -19.31 82.51 REMARK 500 ASN A 724 62.05 73.70 REMARK 500 ASN B 506 64.71 -117.57 REMARK 500 ARG B 622 -28.51 87.54 REMARK 500 ASP B 623 51.48 -140.12 REMARK 500 ARG B 675 17.72 58.72 REMARK 500 ASN B 724 63.06 67.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LWJ A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LWJ B 801 DBREF 5B7V A 456 765 UNP P11362 FGFR1_HUMAN 456 765 DBREF 5B7V B 456 765 UNP P11362 FGFR1_HUMAN 456 765 SEQADV 5B7V VAL A 457 UNP P11362 LEU 457 ENGINEERED MUTATION SEQADV 5B7V ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 5B7V SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 5B7V VAL B 457 UNP P11362 LEU 457 ENGINEERED MUTATION SEQADV 5B7V ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 5B7V SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 A 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 A 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 A 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 A 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 A 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 A 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 A 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 A 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 A 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 A 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 A 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 A 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 A 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 A 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 A 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 A 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 A 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 A 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 A 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 A 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 A 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 A 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 A 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 B 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 B 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 B 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 B 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 B 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 B 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 B 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 B 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 B 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 B 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 B 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 B 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 B 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 B 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 B 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 B 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 B 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 B 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 B 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 B 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 B 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 B 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 B 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET LWJ A 801 27 HET SO4 A 802 5 HET LWJ B 801 27 HETNAM LWJ [5-AMINO-1-(2-METHYL-1H-BENZIMIDAZOL-6-YL)-1H-PYRAZOL- HETNAM 2 LWJ 4-YL](1H-INDOL-2-YL)METHANONE HETNAM SO4 SULFATE ION FORMUL 3 LWJ 2(C20 H16 N6 O) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *75(H2 O) HELIX 1 AA1 PRO A 474 ASP A 476 5 3 HELIX 2 AA2 THR A 521 GLY A 539 1 19 HELIX 3 AA3 ASN A 568 ALA A 575 1 8 HELIX 4 AA4 SER A 596 LYS A 617 1 22 HELIX 5 AA5 ALA A 625 ARG A 627 5 3 HELIX 6 AA6 LEU A 662 MET A 667 5 6 HELIX 7 AA7 ALA A 668 ARG A 675 1 8 HELIX 8 AA8 THR A 678 THR A 695 1 18 HELIX 9 AA9 PRO A 705 GLU A 715 1 11 HELIX 10 AB1 THR A 726 TRP A 737 1 12 HELIX 11 AB2 VAL A 740 ARG A 744 5 5 HELIX 12 AB3 THR A 746 THR A 761 1 16 HELIX 13 AB4 PRO B 474 ASP B 476 5 3 HELIX 14 AB5 THR B 521 GLY B 539 1 19 HELIX 15 AB6 ASN B 568 ARG B 576 1 9 HELIX 16 AB7 SER B 596 LYS B 617 1 22 HELIX 17 AB8 ALA B 625 ARG B 627 5 3 HELIX 18 AB9 LEU B 662 MET B 667 5 6 HELIX 19 AC1 ALA B 668 ASP B 674 1 7 HELIX 20 AC2 THR B 678 THR B 695 1 18 HELIX 21 AC3 PRO B 705 GLU B 715 1 11 HELIX 22 AC4 THR B 726 TRP B 737 1 12 HELIX 23 AC5 VAL B 740 ARG B 744 5 5 HELIX 24 AC6 THR B 746 LEU B 760 1 15 SHEET 1 AA1 5 LEU A 478 GLY A 485 0 SHEET 2 AA1 5 VAL A 492 ILE A 498 -1 O LEU A 494 N LYS A 482 SHEET 3 AA1 5 VAL A 508 LYS A 514 -1 O VAL A 513 N VAL A 493 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 GLY B 485 0 SHEET 2 AA3 5 GLN B 491 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 AA3 5 VAL B 508 MET B 515 -1 O THR B 509 N ALA B 497 SHEET 4 AA3 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 11 ALA A 512 GLU A 531 VAL A 561 GLU A 562 SITE 2 AC1 11 TYR A 563 ALA A 564 SER A 565 GLY A 567 SITE 3 AC1 11 LEU A 630 ASP A 641 PHE A 642 SITE 1 AC2 3 ARG A 470 LYS A 618 HIS A 679 SITE 1 AC3 12 LEU B 484 VAL B 492 ALA B 512 GLU B 531 SITE 2 AC3 12 VAL B 561 GLU B 562 TYR B 563 ALA B 564 SITE 3 AC3 12 GLY B 567 LEU B 630 ASP B 641 PHE B 642 CRYST1 211.210 56.750 65.450 90.00 107.43 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004735 0.000000 0.001486 0.00000 SCALE2 0.000000 0.017621 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016014 0.00000